Risk of death twice as high among cancer patients with COVID-19
May 29, 2020
Mays Cancer Center faculty members authored the data analysis involving more than 900 cancer patients.
Cancer drugs cause large cells that resist treatment; scientist aims to stop it
May 28, 2020
Fueled by genetic changes due to cancer therapy itself, rogue cells may become very large with twice or quadruple the number of chromosomes found in healthy cells. Dr. Daruka Mahadevan, of the Mays Cancer Center, seeks to find drugs that prevent or treat this problem.
Results published of remdesivir, COVID-19 trial
May 28, 2020
According to the study, the drug improved recovery time and decreased the number of deaths.
Faculty present their innovations at virtual pitch day
May 22, 2020
Nine UT Health San Antonio clinicians and scientists pitched their innovations in the President’s Translational and Entrepreneurial Research Fund (PTEF) virtual forum held May 20.
Second phase of clinical trial for promising COVID-19 drug begins
May 15, 2020
Second phase includes FDA-approved anti-inflammatory drug along with remdesivir.
Don’t let COVID-19 keep you from getting stroke care
May 13, 2020
Even during the COVID-19 pandemic, patients should never hesitate to call an ambulance if they have signs of a stroke
